MYD88 and B-cell neoplasm: Since leukemic MZL (mainly SMZL) is the mature B-cell neoplasm that most frequently displays a nonspecific phenotype, and up to 20% of such cases may present MYD88 L265P mutation, differential diagnosis with SMZL was made with special thoroughness.